Maintenance Treatment of Major Depression in Old Age
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elderly patients with major depression, including those having a first episode, are at high risk for recurrence of depression, disability, and death. METHODS: We tested the efficacy of maintenance paroxetine and monthly interpersonal psychotherapy in patients 70 years of age or older who had depression (55 percent of whom were having a first episode) in a 2-by-2, randomized, double-blind, placebo-controlled trial. Among patients with a response to treatment with paroxetine and psychotherapy, 116 were randomly assigned to one of four maintenance-treatment programs (either paroxetine or placebo combined with either monthly psychotherapy or clinical-management sessions) for two years or until the recurrence of major depression. Clinical-management sessions, conducted by the same nurses, social workers, and psychologists who provided psychotherapy, involved discussion of symptoms. RESULTS: Major depression recurred within two years in 35 percent of the patients receiving paroxetine and psychotherapy, 37 percent of those receiving paroxetine and clinical-management sessions, 68 percent of those receiving placebo and psychotherapy, and 58 percent of those receiving placebo and clinical-management sessions (P=0.02). After adjustment for the effect of psychotherapy, the relative risk of recurrence among those receiving placebo was 2.4 times (95 percent confidence interval, 1.4 to 4.2) that among those receiving paroxetine. The number of patients needed to be treated with paroxetine to prevent one recurrence was 4 (95 percent confidence interval, 2.3 to 10.9). Patients with fewer and less severe coexisting medical conditions (such as hypertension or cardiac disease) received greater benefit from paroxetine (P=0.03 for the interaction between treatment with paroxetine and baseline severity of medical illness). CONCLUSIONS: Patients 70 years of age or older with major depression who had a response to initial treatment with paroxetine and psychotherapy were less likely to have recurrent depression if they received two years of maintenance therapy with paroxetine. Monthly maintenance psychotherapy did not prevent recurrent depression. (ClinicalTrials.gov number, NCT00178100.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second, we utilized a dual-criterion threshold for determining clinical relapse (SCID and HRSD); while commonly used (Klein et al., 2004, Reynolds et al., 2006), this approach prioritizes confidence in relapse events at the expense of excluding partial relapse phenomena.”
From Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial (2022) · cites this paper as Reynolds et al., 2006
In the citing paper
“These failed trials involved antidepressants such as tricyclic antidepressants (Maj et al., 1992), SSRIs (Wilson et al., 2003; Reynolds et al., 2006), the anxiolytic SNRI milnacipran (Rouillon et al., 2000), and a preparation of the plant Hypericum perforatum (St. John’s Wort; Kasper et al., 2008).”
From Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2016) · cites this paper as Reynolds et al., 2006
In the citing paper
“Late-life depression (LLD) is a common and debilitating condition, with less frequent remission and more frequent recurrence following first-line antidepressant treatment compared to depression experienced earlier in life1–7.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [2]
In the citing paper
“Continuing antidepressant medication in those who have initially done well appears to be effective in preventing relapse during 6‐12 months of continuation therapy, and in preventing recurrence for up to three years during longer‐term maintenance treatment, with reported numbers needed to treat of about 4 219 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [219]
In the citing paper
“Antidepressants, psychotherapy, or a combination reduce the relapse and recurrence rates of late-life major depression137–139.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [138]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Self-citationHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650
Psychological Assessment Resources
Abidin, R. R. (1995) · Medical Entomology and Zoology · Cited by 3,147
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990
Self-citationStructured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Interpersonal Psychotherapy Of Depression
Klerman, G. L. (1984) · Medical Entomology and Zoology · Cited by 1,315
Research works printed but not linked: 4
- Zis AP, 1980, Psychopharmacol Bull, 16, 47
- Wagner EF, 1992, J Psychother Pract Res, 22, 281
- 10.1097/00004850-199611020-00008 · DOI · Paper page
- Wilson K, 2001, Cochrane Database Syst Rev, 2, CD000561
Cited by
Items 101–200 of 472
Lavretsky, H., Laird, K. T., Krause-Sorio, B., Heimberg, B. F., Yeargin, J., Grzenda, A., Wu, P., Thana-Udom, K., Ercoli, L. M., & Siddarth, P. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.08.011 · Cited by 61
The Relationship Between Spiritual Well-Being and Quality of Life Among Elderly People
Jadidi, A., Farahaninia, M., Janmohammadi, S., & Haghani, H. (2015) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000081 · Cited by 72
Scheier, M. F., Helgeson, V. S., Schulz, R., Colvin, S., Berga, S. L., Knapp, J., & Gerszten, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7093 · Cited by 59
“This effect is similar conceptually to the general pattern of effects obtained for our psychosocial moderators, as well as the results reported by Reynolds et al.43 However, the opposite was true when we examined the effects of the education intervention on individuals with different levels of comorbidities.”
Couteur, D. G. L., Hilmer, S. N., Glasgow, N., Naganathan, V., & Cumming, R. G. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg006.pub2 · Cited by 59
Publication Bias and the Efficacy of Antidepressants
Mathew, S. J., & Charney, D. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071102 · Cited by 63
Psychiatric Disease in the Twenty-First Century: The Case for Subcortical Ischemic Depression
Taylor, W. D., Steffens, D. C., & Krishnan, K. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.028 · Cited by 56
Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review
Gebara, M. A., Shea, M. L. O., Lipsey, K. L., Teitelbaum, S. L., Civitelli, R., Müller, D. J., Reynolds, C. F., Mulsant, B. H., & Lenze, E. J. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12945 · Cited by 65
“In addition, when short-term treatment with an SRI antidepressant leads to remission of late-life depression, long-term maintenance treatment prevents recurrence.(47) There are many evidence-based psychosocial approaches to late-life depression—including cognitive-behavioral therapy, problemsolving therapy, and guided…”
BackgroundSelf-citationDisruption of Neural Homeostasis as a Model of Relapse and Recurrence in Late-Life Depression
Andreescu, C., Ajilore, O., Aizenstein, H. J., Albert, K., Butters, M. A., Landman, B. A., Karim, H. T., Krafty, R., & Taylor, W. D. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.07.016 · Cited by 56
Self-citationDepression in older cat and dog owners: the Nord-Trøndelag Health Study (HUNT)-3
Enmarker, I., Hellzèn, O., Ekker, K., & Berg, A. T. (2014) · Aging & Mental Health · doi:10.1080/13607863.2014.933310 · Cited by 68
“Depression has a strong tendency to recur in older people (Reynolds et al., 2006).”
BackgroundOlder Adults With Severe, Treatment-Resistant Depression
Unützer, J., & Park, M. (2012) · JAMA · doi:10.1001/2012.jama.10690 · Cited by 54
Marshe, V. S., Maciukiewicz, M., Rej, S., Tiwari, A. K., Sibille, E., Blumberger, D. M., Karp, J. F., Lenze, E. J., Reynolds, C. F., Kennedy, J. L., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050617 · Cited by 54
Self-citationIncomplete remission in depression: role of psychiatric and somatic comorbidity
Otte, C. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/cotte · Cited by 68
“Importantly, patients with fewer and less severe coexisting medical illness received greater benefit from paroxetine as indicated by a significant interaction between treatment with paroxetine and baseline severity of medical illness (Figure 2).(53) These results indicate that medical illness might not only affect rem…”
Hegerl, U., & Mergl, R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106930 · Cited by 56
Paroxetine: current status in psychiatry
Pae, C.-U., & Patkar, A. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.2.107 · Cited by 53
Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression
Dunlop, B. W. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20150042 · Cited by 110
Möller, H.-J., Bitter, I., Bobes, J., Fountoulakis, K., Höschl, C., & Kasper, S. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.08.002 · Cited by 53
“depressive episode and the risk of relapse [16,44,149,198] require an effective drug treatment that simultaneously reduces suicidal”
BackgroundSong, R., Kosorok, M. R., Zeng, D., Zhao, Y., Laber, E. B., & Yuan, M. (2015) · Stat · doi:10.1002/sta4.78 · Cited by 68
“…trials where medical decision-making is needed, qualitative interaction tests (Gail & Simon, 1985; Piantadosi & Gail, 1993; Yan, 2004) have been used to test a small number of expert-determined prespecified interactions, such as The ALLHAT Officers and Coordinators (2002) and Reynolds et al. (2006).”
MethodAndreescu, C., & Reynolds, C. F. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.005 · Cited by 52
“Moreover, patients treated with paroxetine for 2 years were less likely to have recurrent depression, whereas maintenance psychotherapy did not prevent recurrences.(16)”
BackgroundMethodInfluentialSelf-citationMagnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression
Aizenstein, H. J., Khalaf, A., Walker, S. E., & Andreescu, C. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516541 · Cited by 53
“This article provides a review of the current literature using structural and functional neuroimaging to identify MRI predictors of treatment response in LLD.”
BackgroundInfluentialKlein, J. P., Berger, T., Schröder, J., Späth, C., Meyer, B., Caspar, F., Lutz, W., Greiner, W., Hautzinger, M., Rose, M., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-239 · Cited by 51
“The 24item version is used to allow for comparisons with other depression trials [42,43].”
BackgroundMethodRisk–benefit analysis of antidepressant drug treatment in the elderly
Álamo, C., López‐Muñoz, F., García‐García, P., & García‐Ramos, S. (2014) · Psychogeriatrics · doi:10.1111/psyg.12057 · Cited by 49
Reynolds, C. F., Dew, M. A., Martire, L. M., Miller, M. D., Cyranowski, J. M., Lenze, E., Whyte, E. M., Mulsant, B. H., Pollock, B. G., Karp, J. F., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2443 · Cited by 49
“These study clinicians had participated in previous studies of maintenance IPT in late-life depression (Reynolds et al., 1999; Reynolds et al., 2006).”
Self-citationLate-Life Depression: A Narrative Review on Risk Factors and Prevention
Vyas, C. M., & Okereke, O. I. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000240 · Cited by 58
Treatment of Depression in Older Adults
Bottino, C. M. C., Barcelos‐Ferreira, R., & Ribeiz, S. R. I. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0281-z · Cited by 55
Interpersonal Psychotherapy: A Scoping Review and Historical Perspective (1974–2017)
Ravitz, P., Watson, P., Lawson, A., Constantino, M. J., Bernecker, S. L., Park, J., & Swartz, H. A. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000219 · Cited by 58
Use of Antidepressants in Late-Life Depression
Rajji, T. K., Mulsant, B. H., Lotrich, F. E., Lokker, C., & Reynolds, C. F. (2008) · Drugs & Aging · doi:10.2165/00002512-200825100-00003 · Cited by 52
Self-citationCheston, R., & Ivanecka, A. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4529 · Cited by 61
“Additionally, RCTs do not, on their own address the challenges of defining appropriate outcomes: for instance whether the goal of psychotherapy be to improve insight, to reduce anxiety and depression or to reduce challenging behaviour and carer stress?”
MethodInfluentialWilliams, M. M., Clouse, R. E., Nix, B. D., Rubin, E. H., Sayuk, G. S., McGill, J. B., Gelenberg, A. J., Ciechanowski, P. S., Hirsch, I. B., & Lustman, P. J. (2007) · Diabetes Care · doi:10.2337/dc06-1825 · Cited by 46
fMRI activation in late‐life anxious depression: a potential biomarker
Andreescu, C., Butters, M., Lenze, E. J., Venkatraman, V. K., Nable, M., Reynolds, C. F., & Aizenstein, H. J. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2327 · Cited by 44
Self-citationDiferentes faces da depressão no suicídio em idosos
Cavalcante, F. G., Minayo, M. C. D. S., & Mangas, R. M. D. N. (2013) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232013001000023 · Cited by 157
Lisanby, S. H., McClintock, S. M., Alexopoulos, G. S., Bailine, S. H., Bernhardt, E. R., Briggs, M. C., Cullum, C. M., Deng, Z., Dooley, M. J., Geduldig, E. T., et al. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.10.003 · Cited by 50
“In many cases, elderly adults receive little to no benefit from antidepressant therapies including pharmacotherapy (4), psychotherapy (5), and repetitive transcranial magnetic stimulation (6), or require rapidly-acting intervention, and thus are prescribed electroconvulsive therapy (ECT) (7).”
BackgroundMaintenance study for adolescent depression
Cheung, A., Kusumakar, V., Kutcher, S., Dubo, E., Garland, J., Weiss, M., Kiss, A., & Levitt, A. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0001 · Cited by 44
“…treatment with antidepressants after acute response is critical in preventing recurrence in patients with major depression (Franchini et al. 1999, Perahia et al. 2006, Reynolds et al. 2006) and there is emerging evidence that the same is true for the adolescent population (Emslie et al. 2004).”
Psychosocial Treatment Options for Major Depressive Disorder in Older Adults
Renn, B. N., & Areán, P. A. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0100-6 · Cited by 48
Continuation and maintenance treatments for depression in older people
Wilkinson, P., & Izmeth, Z. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006727.pub2 · Cited by 43
Lotrich, F. E., Pollock, B. G., Kirshner, M., Ferrell, R. F., & Reynolds, C. F. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0814 · Cited by 42
“Benzodiazepines could be provided as needed.(29,30)”
Self-citationThe MMSE is not an adequate screening cognitive instrument in studies of late-life depression
Rajji, T. K., Miranda, D., Mulsant, B. H., Lotz, M., Houck, P., Zmuda, M. D., Bensasi, S., Reynolds, C. F., & Butters, M. A. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.06.002 · Cited by 43
“Similarly, 49 subjects, age 60 and above, were participants in the late-life total sleep deprivation (LLTSD) (Reynolds et al., 2005) and were recruited between November 1998 and August 2003 at WPIC; 132 subjects age 70 and above, were participants in the maintenance therapies in late-life depression II (MTLD-II) (Reyn…”
BackgroundMethodSelf-citationCarreira, K., Miller, M. D., Frank, E., Houck, P. R., Morse, J. Q., Dew, M. A., Butters', M. A., & Reynolds, C. F. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2031 · Cited by 42
“As noted in the report of the parent study (Reynolds et al., 2006), the four maintenance treatment groups did not differ in sociodemographic, and clinical measures, Mattis scores, or extent of coexisting medical burden.”
BackgroundMethodResultSelf-citationGunter, L., Zhu, J., & Murphy, S. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.608052 · Cited by 41
“There are currently only a few qualitative interaction tests that can be used to test a small number of prespecified interactions (ALLHAT Collaborative Research Group, 2002; Gail and Simon, 1985; Krystal et al., 2001; Pan and Wolfe, 1997; Reynolds et al., 2006; Shuster and Van Eys, 1983; Silvapulle, 2001; Yan, 2004; Y…”
BackgroundHoertel, N., McMahon, K., Olfson, M., Wall, M. M., Rodríguez-Fernández, J. M., Lemogne, C., Limosin, F., & Blanco, C. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.017 · Cited by 40
“The two later age groups offer the opportunity to detect a change of the metastructure of common psychiatric disorders that could occur later in life and would thus have been blurred by merging all participants older than 65 years of age (Reynolds et al., 2006).”
BackgroundPharmacological management of unipolar depression
Malhi, G. S., Hitching, R., Berk, M., Boyce, P., Porter, R., & Fritz, K. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12122 · Cited by 42
Hummel, J., Weisbrod, C., Boesch, L., Himpler, K., Hauer, K. A., Hautzinger, M., Gäbel, A., Zieschang, T., Fickelscherer, A., Diener, S. J., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.10.009 · Cited by 48
A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders
Lenze, E. J., Rodebaugh, T. L., & Nicol, G. E. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0114 · Cited by 45
Self-citationDonohue, J. M., Zhang, Y., Perera, S., Lave, J. R., Hanlon, J. T., Men, A., & Reynolds, C. F. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182051a9b · Cited by 43
Self-citationTreatment-Resistant Late-Life Depression
Subramanian, S., Oughli, H. A., Gebara, M. A., Palanca, B. J. A., & Lenze, E. J. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.008 · Cited by 77
Self-citationGarden Walking and Art Therapy for Depression in Older Adults: A Pilot Study
McCaffrey, R. G., Liehr, P. R., Gregersen, T., & Nishioka, R. (2011) · Research in Gerontological Nursing · doi:10.3928/19404921-20110201-01 · Cited by 48
Brown, P. J., Ciarleglio, A., Roose, S. P., Garcia, C. M., Chung, S., Fernandes, S. M. S. R., & Rutherford, B. R. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab338 · Cited by 42
The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology
Pollock, B. G., Forsyth, C., & Bies, R. R. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.229 · Cited by 39
Self-citationStudies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
El-Mallakh, R. S., & Briscoe, B. (2012) · CNS Drugs · doi:10.2165/11599450-000000000-00000 · Cited by 36
Miller, M. D. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0005-6 · Cited by 40
“The MTLD-II [ 26 ] study design was similar to that of its predecessor but focused on adults aged 65 and older with very few exclusions for medical reasons.”
MethodSelf-citationWilkinson, P., Alder, N., Juszczak, E., Matthews, H., Merritt, C., Montgomery, H., Howard, R., Macdonald, A., & Jacoby, R. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2076 · Cited by 36
Florea, I., Danchenko, N., Brignone, M., Loft, H., Rive, B., & Abetz-Webb, L. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.08.008 · Cited by 35
Antidepressant Prescription and Suicide Rates: Effect of Age and Gender
Kalmár, S., Szántó, K., Rihmer, Z., Mazumdar, S., Harrison, K., & Mann, J. J. (2008) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2008.38.4.363 · Cited by 43
Self-citationLü, Y., Arthur, D., Hu, L., Cheng, G., Feng-rong, A., & Li, Z. (2015) · International Journal of Mental Health Nursing · doi:10.1111/inm.12181 · Cited by 39
“For example, one study claimed that the relative risk of recurrence of symptoms among patients receiving placebo was 2.4 times that of those receiving 2-year maintenance therapy with paroxetine (Reynolds et al. 2006).”
BackgroundResultInfluentialTreatment of Late‐Life Depression Alleviates Caregiver Burden
Martire, L. M., Schulz, R., Reynolds, C. F., Karp, J. F., Gildengers, A. G., & Whyte, E. M. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02610.x · Cited by 45
Self-citationManagement of Late-Life Depression
Nelson, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_170 · Cited by 43
Karp, J. F., Weiner, D. K., Dew, M. A., Begley, A. E., Miller, M. D., & Reynolds, C. F. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2386 · Cited by 40
“…assessed with the CIRS-G, was higher (mean¼ 11.6) than several other studies of late-life depression, where the average CIRS-G scores ranged from 3.7 to 10.0 (Reynolds et al., 1999; Adeoye et al., 2003; Taylor et al., 2004; Lyness et al., 2006; Reynolds et al., 2006; Chapman et al., 2007).”
ResultInfluentialSelf-citationHamilton Rating Scale for Depression (HAM-D)
Shahid, A., Wilkinson, K., Marcu, S., & Shapiro, C. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9893-4_42 · Cited by 38
Driscoll, H. C., Karp, J. F., Dew, M. A., & Reynolds, C. F. (2007) · Drugs & Aging · doi:10.2165/00002512-200724100-00002 · Cited by 38
Self-citationLehmann, S. W., & Rabins, P. V. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1607 · Cited by 37
“Recent evidence indicates that maintenance treatment of major depression in old age prevents relapse (Reynolds et al., 2006).”
BackgroundAndreescu, C., Lenze, E. J., Mulsant, B. H., Wetherell, J. L., Begley, A. E., Mazumdar, S., & Reynolds, C. F. (2009) · Depression and Anxiety · doi:10.1002/da.20544 · Cited by 33
“In the previously reported parent study, maintenance IPTwas not shown to have an effect on time to recurrence or rates of recurrence of major depressive episodes.([18]) The analyses were performed using SAS Proc Factor, version 9.”
MethodSelf-citationRucci, P., Frank, E., Calugi, S., Miniati, M., Benvenuti, A., Wallace, M., Fagiolini, A., Maggi, L., Kupfer, D. J., & Cassano, G. B. (2011) · Depression and Anxiety · doi:10.1002/da.20894 · Cited by 33
“[21–25] The Frank et al.”
Self-citationBagher, S. M., Alfaghari, P. Z., Mahdizadeh, F., Aghayan, S. M., Aghmashhadi, M. G., Shariati, Z., & Khosravi, A. (2008) · doi:10.22100/jkh.v3i2.212 · Cited by 32
An integrated model for defining the scope of psychogeriatrics: the five Cs
Sadavoy, J. (2009) · International Psychogeriatrics · doi:10.1017/s104161020999010x · Cited by 38
Cohen, A., & Gureje, O. (2007) · International Review of Psychiatry · doi:10.1080/09540260701564880 · Cited by 31
“…options for treatment (medication and individual or group psychotherapy), and primary care staff whose job it is to coordinate care and follow patients (Craven & Bland, 2006; Katon, Von Korff, Lin, & Simon, 2001; Katon et al., 2004; Reynolds et al., 2006; Simon, 2006; Unutzer et al., 2002).”
BackgroundLavretsky, H., Siddarth, P., Kumar, A., & Reynolds, C. F. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1837 · Cited by 31
Self-citationPsychological Treatment of Late-Life Depression
Francis, J., & Kumar, A. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.08.005 · Cited by 35
Population Pharmacokinetics in Geriatric Psychiatry
Bigos, K. L., Bies, R. R., & Pollock, B. G. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224330.73063.6c · Cited by 30
Self-citationPrevention of depressive disorders: a brave new world
Reynolds, C. F. (2009) · Depression and Anxiety · doi:10.1002/da.20644 · Cited by 30
“In the studies cited above, NNT’s in the range of 7–9 are typical for ‘‘preemption’’ and about 4 for ‘‘protection’’ from recurrences.([10]) These estimates of NNTcontrast favorably with an NNTof 21 in four large trials of statins for the prevention of a second myocardial infarction.”
BackgroundSelf-citationLiang, J.-H., Li, J., Wu, R.-K., Li, J.-Y., Qian, S., Jia, R.-X., Wang, Y.-Q., Qian, Y., & Xu, Y. (2020) · European Child and Adolescent Psychiatry · doi:10.1007/s00787-020-01492-w · Cited by 23
“This structural and time-limited therapy efficaciously treats depression both in youth and adults, which was even applied in elderly adults [63, 64], and highly recommended by early and recent meta-analytic review [65, 66].”
BackgroundIntensive Session: New Approaches to Medical Issues in Long-Term Care
Messinger‐Rapport, B. J., Morley, J. E., Thomas, D. R., & Gammack, J. K. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.07.002 · Cited by 29
Major depression, physical health and molecular senescence markers abnormalities
Seitz‐Holland, J., Mulsant, B. H., Reynolds, C. F., Blumberger, D. M., Karp, J. F., Butters, M. A., Mendes‐Silva, A. P., Vieira, É. L. M., Tseng, G. C., Lenze, E. J., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00033-z · Cited by 32
“Previous studies have demonstrated a robust bidirectional relationship between LLD and physical health 6 and the mediating effect of medical conditions on treatment outcomes 45 .”
BackgroundSelf-citationAbraham, J., Holzer, K. J., Lenard, E. M., Meng, A., Pennington, B. R. T., Wolfe, R. C., Haroutounian, S., Calfee, R. P., Hammil, C. W., Kozower, B. D., et al. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.09.003 · Cited by 31
Self-citationOptimizing treatment for older adults with depression
Srifuengfung, M., Pennington, B. R. T., & Lenze, E. J. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231212327 · Cited by 39
“31,32 Guidelines provided by the Japanese Society of Mood Disorders, Indian Psychiatric Society, and Canadian Coalition for Seniors’ Mental Health recommend maintaining the antidepressant at the same dosage for at least 1 year after remission.”
BackgroundSelf-citationInterpersonal psychotherapy as a treatment for depression in later life.
Hinrichsen, G. A. (2008) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.39.3.306 · Cited by 31
Variable Selection for Optimal Decision Making
Gunter, L., Zhu, J., & Murphy, S. A. (2007) · Lecture notes in computer science · doi:10.1007/978-3-540-73599-1_17 · Cited by 28
“In medical decision making applications such as clinical trials, the combination of predictive variable selection techniques and statistical testing of a small number of interaction variables suggested by expert opinion are most commonly used [4, 5].”
BackgroundDepression, cardiac mortality and all-cause mortality
Seymour, J., & Benning, T. B. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004770 · Cited by 33
Gallarda, T., & Lôo, H. (2009) · L Encéphale · doi:10.1016/j.encep.2008.10.013 · Cited by 39
Depression in older age: A scoping study
Haralambous, B., Tinney, J., & Bryant, C. (2009) · Cited by 34
Dombrovski, A. Y., Blakesley-Ball, R. E., Mulsant, B. H., Mazumdar, S., Houck, P. R., Szanto, K., & Reynolds, C. F. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000218325.76196.d1 · Cited by 27
Self-citationFive-year trajectories of social networks and social support in older adults with major depression
Voils, C. I., Allaire, J. C., Olsen, M. K., Steffens, D. C., Hoyle, R. H., & Bosworth, H. B. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005303 · Cited by 34
“Study participants were outpatients aged 59 or older with a Center for Epidemiologic Studies Depression Scale ( Radloff, 1977 ) score of 16 or above or a diagnosis of major depression.”
MethodHegerl, U., Allgaier, A., Henkel, V., & Mergl, R. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.015 · Cited by 29
Depression in Late-Life: A Focus on Prevention
Okereke, O. I., Lyness, J. M., Lotrich, F. E., & Reynolds, C. F. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.22 · Cited by 29
“Considerable success has already been achieved in identifying maintenance treatments as effective strategies for prevention of relapse and recurrence among older adults with established histories of treated depression(1, 2).”
BackgroundSelf-citationMaust, D. T., Oslin, D. W., & Thase, M. E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.030 · Cited by 25
“risk of relapse higher than that observed in younger adults,(13) whereas older patients who achieve remission following initial treatment with psychotherapy and AD monotherapy are less likely to have recurrent depression on maintenance pharmacotherapy.(14) Although the syndrome of major depressive disorder (MDD) descr…”
Review of treatment for late-life depression
Allan, C. L., & Ebmeier, K. P. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.010835 · Cited by 28
Möller, H. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903101665 · Cited by 25
Krijnen-de Bruin, E., Scholten, W., Muntingh, A., Maarsingh, O., van Meijel, B., van Straten, A., & Batelaan, N. (2022) · PLOS ONE · doi:10.1371/journal.pone.0272200 · Cited by 23
“IPT was not included in the subgroup analysis for type of intervention, as only one study was available with results up to and including 24 months [62].”
MethodResilience predicts remission in antidepressant treatment of geriatric depression
Laird, K. T., Lavretsky, H., St. Cyr, N., & Siddarth, P. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4953 · Cited by 23
Psychotherapy for comorbid depression and somatic disorders: a systematic review and meta-analysis
Miguel, C., Karyotaki, E., Čihařová, M., Cristea, I. A., Penninx, B. W. J. H., & Cuijpers, P. J. (2021) · Psychological Medicine · doi:10.1017/s0033291721004414 · Cited by 26
“This has also been observed with antidepressant pharmacotherapy, where the severity of the comorbid somatic disorders may moderate short-and long-term effects (Reynolds et al., 2006).”
Quality Indicators for the Care of Depression in Vulnerable Elders
Nakajima, G. A., & Wenger, N. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01336.x · Cited by 25
“2) that of patients continuing treatment.(100) An earlier trial by the same group found that continuing maintenance treatment with nortriptyline was superior to placebo.”
BackgroundKaplan, C. M., & Zhang, Y. (2012) · PubMed · Cited by 24
Seripa, D., Pilotto, A., Paroni, G., Fontana, A., D’Onofrio, G., Gravina, C., Urbano, M., Cascavilla, L., Paris, F., Panza, F., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115578159 · Cited by 23
“…in other age groups, stems from the unique psychosocial and biological factors associated with aging, including the presence of significant comorbidities, cognitive impairment and functional disability (Alexopoulos, 2005; Blazer, 2003; Lebowitz et al., 1997; Reynolds et al., 2006; Unützer, 2007).”
BackgroundShould antidepressant medication be used in the elderly?
Taylor, W. D. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1070671 · Cited by 25
“Meanwhile, although late-life depression has high rates of relapse, maintenance antidepressant treatment can reduce relapse rates [13].”
BackgroundRemission in major depression: results from a geriatric primary care population
Azar, A. R., Chopra, M. P., Cho, L. Y., Coakley, E., & Rudolph, J. L. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2485 · Cited by 22
“…of the factors shown to be associated with non-response and non-remission in previous treatment studies include comorbid anxiety symptoms or disorder and medical comorbidity (Oslin et al., 2002; Alexopoulos et al., 2005; Steffens and McQuoid, 2005; Reynolds et al., 2006; Andreescu et al., 2007).”
BackgroundInfluentialMechanisms and treatment of late-life depression
Alexopoulos, G. S. (2021) · Focus · doi:10.1176/appi.focus.19304 · Cited by 22
Maust, D. T., Oslin, D. W., & Thase, M. E. (2012) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31826576cf · Cited by 22
Nishtala, P. S., McLachlan, A. J., Bell, J. S., & Chen, T. F. (2009) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2009.07.001 · Cited by 22
Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review
Bosman, R. C., Waumans, R. C., Jacobs, G. E., Oude Voshaar, R. C., Muntingh, A. D. T., Batelaan, N. M., & van Balkom, A. J. L. M. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491550 · Cited by 21
Kolko, D. J., Lindhiem, O. J., Hart, J., & Bukstein, O. G. (2013) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-013-9724-1 · Cited by 23
“In general, booster or maintenance treatment has been directed towards responders or those who show diagnostic remission in adult psychotherapy studies (Frank et al. 2007; Petersen et al. 2010; Reynolds et al. 2006), with some exceptions (Dunner et al. 2007).”
InfluentialThe Use of Selective Serotonin Reuptake Inhibitors in Elderly Patients
Chemali, Z. N., Chahine, L. M., & Fricchione, G. L. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220903129798 · Cited by 25
Benson, C. J., Szukis, H., Sheehan, J. J., Alphs, L. D., & Yüce, H. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.10.012 · Cited by 24
Metadata
- Authors
- Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., Schlernitzauer, M. A., Whyte, E. M., Gildengers, A., Karp, J., Lenze, E., Szanto, K., Bensasi, S., & Kupfer, D. J.
- Affiliations
- University of Pittsburgh (US)
- Geriatric Research Education and Clinical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-03-16
- Volume
- 354
- Issue
- 11
- Pages
- 1130-1138
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2064397126
- Cited by
- 476
- References
- 43
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 16 · 2023: 18 · 2022: 11 · 2021: 9 · 2020: 11 · 2019: 27 · 2018: 17 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 19 · 2013: 22 · 2012: 29
- FWCI
- 33.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (K01MH001613, R01 MH37869, K01 MH 01613, P30MH052247, R37 MH43832, R37MH043832, K24 MH65416, K01MH001684, K24MH065416, P30MH071944, P30-MH52247, P30MH030915, P30-MH-30915, R01MH037869, K01MH01684)
- National Institute on Minority Health and Health Disparities (P60MD000207)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- major depressive disorder, older adults, maintenance therapy, paroxetine, interpersonal psychotherapy, depression recurrence, first-episode depression, comorbidities, antidepressant efficacy
- MeSH terms
- Aged, Combined Modality Therapy, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Female, Humans, Male, Psychotherapy, Risk, Comorbidity, Selective Serotonin Reuptake Inhibitors, Paroxetine, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.